| 19904609-2 | 19.904.609 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 500 | | UI | 5 | ml | | | 100 | UI/ml | 500 | PFIZER | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - PFIZER | $914.813,08 | Circular 01 de 2014 | 25/04/2013 0:00 | $64.036,92 |
| 19904609-3 | 19.904.609 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 500 | | UI | 5 | ml | | | 100 | UI/ml | 1.000 | PFIZER | VIGENTE | 2 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 2 - PFIZER | $1.829.626,16 | Circular 01 de 2014 | 25/04/2013 0:00 | $64.036,92 |
| 19904609-4 | 19.904.609 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 500 | | UI | 5 | ml | | | 100 | UI/ml | 2.500 | PFIZER | VIGENTE | 5 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 5 - PFIZER | $4.574.065,41 | Circular 01 de 2014 | 25/04/2013 0:00 | $160.092,29 |
| 19904609-5 | 19.904.609 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 500 | | UI | 5 | ml | | | 100 | UI/ml | 3.000 | PFIZER | VIGENTE | 6 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 6 - PFIZER | $5.488.878,49 | Circular 01 de 2014 | 25/04/2013 0:00 | $192.110,75 |
| 19904609-6 | 19.904.609 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 500 | | UI | 5 | ml | | | 100 | UI/ml | 4.000 | PFIZER | VIGENTE | 8 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 8 - PFIZER | $7.318.504,66 | Circular 01 de 2014 | 25/04/2013 0:00 | $256.147,66 |
| 19904609-7 | 19.904.609 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 500 | | UI | 5 | ml | | | 100 | UI/ml | 5.000 | PFIZER | VIGENTE | 10 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 10 - PFIZER | $9.148.130,82 | Circular 01 de 2014 | 25/04/2013 0:00 | $320.184,58 |
| 19904609-8 | 19.904.609 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 500 | | UI | 5 | ml | | | 100 | UI/ml | 6.000 | PFIZER | VIGENTE | 12 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 12 - PFIZER | $10.977.756,99 | Circular 01 de 2014 | 25/04/2013 0:00 | $384.221,49 |
| 19904610-1 | 19.904.610 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 250 | | UI | 5 | ml | | | 50 | UI/ml | 250 | PFIZER | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 250 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - PFIZER | $457.406,54 | Circular 01 de 2014 | 25/04/2013 0:00 | $32.018,46 |
| 19904610-3 | 19.904.610 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 250 | | UI | 5 | ml | | | 50 | UI/ml | 250 | PFIZER | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 250 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - PFIZER | $457.406,54 | Circular 01 de 2014 | 25/04/2013 0:00 | $32.018,46 |
| 19904610-4 | 19.904.610 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 250 | | UI | 5 | ml | | | 50 | UI/ml | 500 | PFIZER | VIGENTE | 2 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 250 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 2 - PFIZER | $914.813,08 | Circular 01 de 2014 | 25/04/2013 0:00 | $64.036,92 |
| 19904610-5 | 19.904.610 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 250 | | UI | 5 | ml | | | 50 | UI/ml | 1.250 | PFIZER | VIGENTE | 5 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 250 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 5 - PFIZER | $2.287.032,71 | Circular 01 de 2014 | 25/04/2013 0:00 | $80.046,14 |
| 19904610-6 | 19.904.610 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 250 | | UI | 5 | ml | | | 50 | UI/ml | 1.500 | PFIZER | VIGENTE | 6 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 250 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 6 - PFIZER | $2.744.439,25 | Circular 01 de 2014 | 25/04/2013 0:00 | $96.055,37 |
| 19904610-7 | 19.904.610 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 250 | | UI | 5 | ml | | | 50 | UI/ml | 2.000 | PFIZER | VIGENTE | 8 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 250 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 8 - PFIZER | $3.659.252,33 | Circular 01 de 2014 | 25/04/2013 0:00 | $128.073,83 |
| 19904610-8 | 19.904.610 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 250 | | UI | 5 | ml | | | 50 | UI/ml | 2.500 | PFIZER | VIGENTE | 10 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 250 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 10 - PFIZER | $4.574.065,41 | Circular 01 de 2014 | 25/04/2013 0:00 | $160.092,29 |
| 19904610-9 | 19.904.610 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BENEFIX | 250 | | UI | 5 | ml | | | 50 | UI/ml | 3.000 | PFIZER | VIGENTE | 12 | | FACTOR ANTIHEMOFÍLICO IX RECOMBINANTE - Polvo liofilizado p/reconstituir a Sol.Inyectable | BENEFIX - 250 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 12 - PFIZER | $5.488.878,49 | Circular 01 de 2014 | 25/04/2013 0:00 | $192.110,75 |
| 201884-1 | 201.884 | B02BD02 | B02BD02 | COAGULACION FACTORES VIII | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | FANHDI | 500 | | UI | 10 | ml | | | 50 | UI/ml | 500 | GRIFOLS | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO VIII PLASMATICO - Polvo liofilizado p/reconstituir a Sol.Inyectable | FANHDI - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - GRIFOLS | $475.672,70 | Circular 01 de 2014 | 25/04/2013 0:00 | $33.297,09 |
| 201884-2 | 201.884 | B02BD02 | B02BD02 | COAGULACION FACTORES VIII | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | FANHDI | 500 | | UI | 10 | ml | | | 50 | UI/ml | 500 | GRIFOLS | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO VIII PLASMATICO - Polvo liofilizado p/reconstituir a Sol.Inyectable | FANHDI - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - GRIFOLS | $475.672,70 | Circular 01 de 2014 | 25/04/2013 0:00 | $33.297,09 |
| 35076-5 | 35.076 | B02BD02 | B02BD02 | COAGULACION FACTORES VIII | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | HEMOFIL M | 500 | | UI | 10 | ml | | | 50 | UI/ml | 500 | BAXTER | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO VIII PLASMATICO - Polvo liofilizado p/reconstituir a Sol.Inyectable | HEMOFIL M - 500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - BAXTER | $475.672,70 | Circular 01 de 2014 | 25/04/2013 0:00 | $33.297,09 |
| 35076-6 | 35.076 | B02BD02 | B02BD02 | COAGULACION FACTORES VIII | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | HEMOFIL M | 1.000 | | UI | 10 | ml | | | 100 | UI/ml | 1.000 | BAXTER | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO VIII PLASMATICO - Polvo liofilizado p/reconstituir a Sol.Inyectable | HEMOFIL M - 1000 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - BAXTER | $951.345,41 | Circular 01 de 2014 | 25/04/2013 0:00 | $66.594,18 |
| 35076-7 | 35.076 | B02BD02 | B02BD02 | COAGULACION FACTORES VIII | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | HEMOFIL M | 1.500 | | UI | 10 | ml | | | 150 | UI/ml | 1.500 | BAXTER | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO VIII PLASMATICO - Polvo liofilizado p/reconstituir a Sol.Inyectable | HEMOFIL M - 1500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - BAXTER | $1.427.018,11 | Circular 01 de 2014 | 25/04/2013 0:00 | $49.945,63 |
| 35076-8 | 35.076 | B02BD02 | B02BD02 | COAGULACION FACTORES VIII | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | HEMOFIL M | 1.500 | | UI | 10 | ml | | | 150 | UI/ml | 1.500 | BAXTER | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO VIII PLASMATICO - Polvo liofilizado p/reconstituir a Sol.Inyectable | HEMOFIL M - 1500 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - BAXTER | $1.427.018,11 | Circular 01 de 2014 | 25/04/2013 0:00 | $49.945,63 |
| 19913650-1 | 19.913.650 | B02BD04 | B02BD04 | COAGULACION FACTOR IX | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | IMMUNINE | 600 | | UI | | | | | | | 600 | BAXTER | VIGENTE | 1 | | FACTOR ANTIHEMOFÍLICO IX PLASMATICO - Polvo liofilizado p/reconstituir a Sol.Inyectable | IMMUNINE - 600 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - BAXTER | $520.554,29 | Circular 01 de 2014 | 25/04/2013 0:00 | $36.438,80 |
| 19999700-1 | 19.999.700 | L04AX04 | L04AX04 | LENALIDOMIDA | TABLETA / CAPSULA | REVLIMID | 10 | | mg | | | | | | | 210 | CELGENE | VIGENTE | 21 | | LENALIDOMIDA (L04AX04) - TABLETA / CAPSULA | REVLIMID - 10 mg - TABLETA / CAPSULA x 21 - CELGENE | $11.026.057,56 | Circular 04 de 2013 | 14/09/2013 0:00 | $385.912,01 |
| 19999701-1 | 19.999.701 | L04AX04 | L04AX04 | LENALIDOMIDA | TABLETA / CAPSULA | REVLIMID | 5 | | mg | | | | | | | 105 | CELGENE | VIGENTE | 21 | | LENALIDOMIDA (L04AX04) - TABLETA / CAPSULA | REVLIMID - 5 mg - TABLETA / CAPSULA x 21 - CELGENE | $10.442.215,18 | Circular 04 de 2013 | 14/09/2013 0:00 | $365.477,53 |
| 19999772-1 | 19.999.772 | L04AX04 | L04AX04 | LENALIDOMIDA | TABLETA / CAPSULA | REVLIMID | 25 | | mg | | | | | | | 525 | CELGENE | VIGENTE | 21 | | LENALIDOMIDA (L04AX04) - TABLETA / CAPSULA | REVLIMID - 25 mg - TABLETA / CAPSULA x 21 - CELGENE | $12.785.496,47 | Circular 04 de 2013 | 14/09/2013 0:00 | $447.492,38 |
| 19999773-1 | 19.999.773 | L04AX04 | L04AX04 | LENALIDOMIDA | TABLETA / CAPSULA | REVLIMID | 15 | | mg | | | | | | | 315 | CELGENE | VIGENTE | 21 | | LENALIDOMIDA (L04AX04) - TABLETA / CAPSULA | REVLIMID - 15 mg - TABLETA / CAPSULA x 21 - CELGENE | $12.580.681,98 | Circular 04 de 2013 | 14/09/2013 0:00 | $440.323,87 |
| 19911481-1 | 19.911.481 | J05AR10 | J05AE06 | LOPINAVIR Y RITONAVIR | SOLUCION / SUSPENSION ORAL | KALETRA | 12.800 | 3200 | mg | 160 | ml | | | 80 | mg/ml | 12.800 | ABBOTT / ABBVIE | VIGENTE | 1 | | NA | KALETRA - 12800/3200 mg - 160 ml - 80/20 mg/ml - SOLUCION / SUSPENSION ORAL x 1 - ABBOTT / ABBVIE | $56.916,00 | Circular 06 de 2013 | 03/10/2013 0:00 | $3.984,12 |
| 19967068-1 | 19.967.068 | J05AR10 | J05AE06 | LOPINAVIR Y RITONAVIR | TABLETA / CAPSULA | KALETRA | 200 | 50 | mg | | | | | | | 24.000 | ABBOTT / ABBVIE | VIGENTE | 120 | | NA | KALETRA - 200/50 mg - TABLETA / CAPSULA x 120 - ABBOTT / ABBVIE | $108.048,00 | Circular 06 de 2013 | 03/10/2013 0:00 | $7.563,36 |
| 19994092-1 | 19.994.092 | J05AR10 | J05AE06 | LOPINAVIR Y RITONAVIR | TABLETA / CAPSULA | KALETRA | 100 | 25 | mg | | | | | | | 6.000 | ABBOTT / ABBVIE | VIGENTE | 60 | | NA | KALETRA - 100/25 mg - TABLETA / CAPSULA x 60 - ABBOTT / ABBVIE | $27.982,00 | Circular 06 de 2013 | 03/10/2013 0:00 | $1.958,74 |
| 20004997-1 | 20.004.997 | M03AX01 | M03AX01 | TOXINA BOTULINICA | POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE | BOTOX | 50 | | UI | 1 | ml | | | 50 | U/ml | 50 | ALLERGAN | VIGENTE | 1 | | TOXINA BOTULINICA CLOSTRIDIUM TIPO A - Polvo liofilizado p/reconstituir a Sol.Inyectable | BOTOX - 50 UI - POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1 - ALLERGAN | $224.104,37 | Circular 07 de 2013 | 14/01/2014 0:00 | $15.687,31 |